pembrolizumab
merck
['keynote-716', 'key,note,716']
the interviews on the keynote-716 trial. full story coming soon! #asco23 
NCI-designated Comprehensive Cancer Center and a global leader in cancer research and cancer care affiliated with @PittTweet